Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KALME trial of ketamine for analgesia and sedation support in mechanically ventilated ICU adults
ACTRN12622000920796Phase 3Active, not recruiting
- Sponsor
- Austin Health
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in pain comparing Ketamine arm with Placebo control arm (2 arms). Primary endpoint: Total administered opioid dose. Started Sep 2022; status: active, not recruiting.
02
Drugs
ketamine
03
Conditions
pain
Beyond the preview
Go deeper on ACTRN12622000920796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12622000920796.